| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Iris Acquisition Holdings LLC | 26% | 6,900,000 | Iris Acquisition Holdings LLC | 30 Apr 2025 | ||||
| Valetudo Therapeutics LLC | 24% | 6,169,406 | Valetudo Therapeutics LLC | 30 Apr 2025 | ||||
| KH Feelux Co., Ltd | 15% | $20,880,000 | 4,000,000 | KH Feelux Co., Ltd | 30 Apr 2025 | |||
| INTRACOASTAL CAPITAL, LLC | 5% | $1,487,437 | 2,065,885 | Mitchell P. Kopin | 17 Feb 2026 | |||
| Ewon Comfortech Co., Ltd. | 5.8% | $7,830,000 | 1,500,000 | Ewon Comfortech Co., Ltd. | 30 Apr 2025 | |||
| Red Peony Association 1st | 5.7% | $7,673,400 | 1,470,000 | Red Peony Association 1st | 30 Apr 2025 | |||
| Nongae Apple Association 1st | 5.7% | $7,673,400 | 1,470,000 | Nongae Apple Association 1st | 30 Apr 2025 |
As of 31 Dec 2025, 11 institutional investors reported holding 317,192 shares of Liminatus Pharma, Inc. - Common Stock, par value $ 0.0001 per share (LIMN). This represents 0.77% of the company’s total 41,400,501 outstanding shares.